Venky’s (India) Limited (the Company) is establishing a new project for the manufacture of veterinary medical products in the animal health product segment. For this purpose, the company has acquired land with a size of 15030 m² at MIDC, village: Kesurdi, valley: Khandala, district: Satara, Maharashtra. Construction will begin in December 2021 and the project is expected to be completed by March 2023 and commercial production to begin by June 2023.
This project consists in the production of veterinary medicine powder (600 tons / year) and veterinary medicine liquids (300 kiloliters / year) to meet the growing demand of the poultry industry.
The total cost of the project is estimated at Rs. 30.00 kr. Financed from internal provisions.
The proposed facility will be the company’s second facility to meet the latest FDA regulations and is expected to meet export needs as well. The company already has a plant in Pune (Maharashtra) with a capacity of 600 tons / year and this capacity is used at 70-80%.
Venky’s (India) Limited shares were last traded at BSE at Rs. 2593.20 compared to the previous closing price of Rs. 2591.20. The total number of stocks traded during the day was 4,898 in over 1,313 trades.
The stock hit an intraday high of Rs. 2648.00 and an intraday low of 2579.50. Net sales during the day were Rs. 12782265.00.